West Pharmaceutical Services, Inc. (WST)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:04PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 18.61B |
| Enterprise value | 18.22B |
| Trailing P/E | 28.01 |
| Forward P/E | 25.91 |
| PEG ratio (5-yr expected) | 3.33 |
| Price/sales (ttm) | 6.55 |
| Price/book (mrq) | 7.67 |
| Enterprise value/revenue | 6.22 |
| Enterprise value/EBITDA | 20.02 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.18 |
| 52-week change 3 | -39.95% |
| S&P500 52-week change 3 | -16.62% |
| 52-week high 3 | 475.00 |
| 52-week low 3 | 244.71 |
| 50-day moving average 3 | 304.18 |
| 200-day moving average 3 | 347.09 |
Share statistics
| Avg vol (3-month) 3 | 395.89k |
| Avg vol (10-day) 3 | 467.31k |
| Shares outstanding 5 | 74.05M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 73.63M |
| % held by insiders 1 | 0.62% |
| % held by institutions 1 | 96.25% |
| Shares short (14 Sept 2022) 4 | 834.7k |
| Short ratio (14 Sept 2022) 4 | 2.41 |
| Short % of float (14 Sept 2022) 4 | 1.47% |
| Short % of shares outstanding (14 Sept 2022) 4 | 1.13% |
| Shares short (prior month 14 Aug 2022) 4 | 860.5k |
Dividends & splits
| Forward annual dividend rate 4 | 0.72 |
| Forward annual dividend yield 4 | 0.29% |
| Trailing annual dividend rate 3 | 0.71 |
| Trailing annual dividend yield 3 | 0.28% |
| 5-year average dividend yield 4 | 0.36 |
| Payout ratio 4 | 7.92% |
| Dividend date 3 | 02 Aug 2022 |
| Ex-dividend date 4 | 18 Jul 2022 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 26 Sept 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Jun 2022 |
Profitability
| Profit margin | 23.41% |
| Operating margin (ttm) | 26.94% |
Management effectiveness
| Return on assets (ttm) | 15.67% |
| Return on equity (ttm) | 30.76% |
Income statement
| Revenue (ttm) | 2.93B |
| Revenue per share (ttm) | 39.26 |
| Quarterly revenue growth (yoy) | 6.60% |
| Gross profit (ttm) | 1.18B |
| EBITDA | 913M |
| Net income avi to common (ttm) | 685.6M |
| Diluted EPS (ttm) | 8.97 |
| Quarterly earnings growth (yoy) | 0.60% |
Balance sheet
| Total cash (mrq) | 718.5M |
| Total cash per share (mrq) | 9.7 |
| Total debt (mrq) | 332.5M |
| Total debt/equity (mrq) | 13.72 |
| Current ratio (mrq) | 3.13 |
| Book value per share (mrq) | 32.76 |
Cash flow statement
| Operating cash flow (ttm) | 675.2M |
| Levered free cash flow (ttm) | 268.31M |
© 2022 Yahoo. All rights reserved.
